These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19580226)

  • 1. [Statin prescribing in the City of Zagreb (2001-2006) and their role in secondary prevention of cardiovascular events].
    Stimac D; Culig J; John V
    Acta Med Croatica; 2009 May; 63(2):173-7. PubMed ID: 19580226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient utilization of psychopharmaceuticals in the City of Zagreb 2001-2006.
    Stimac D; Culig J
    Psychiatr Danub; 2009 Mar; 21(1):56-64. PubMed ID: 19270622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.
    Cooke C; Nissen L; Sketris I; Tett SE
    Clin Ther; 2005 Apr; 27(4):497-508. PubMed ID: 15922822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of cardiovascular drugs in Zagreb 2001-2005.
    Stimac D; Polić-Vizintin M; Skes M; Cattunar A; Cerović R; Stojanović D
    Acta Cardiol; 2010 Apr; 65(2):193-201. PubMed ID: 20458827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of cardiovascular drugs prescribing in Croatia 2003-2008.
    Stimac D
    Coll Antropol; 2012 Jan; 36 Suppl 1():189-94. PubMed ID: 22338770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland.
    Bennie M; Godman B; Bishop I; Campbell S
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):125-30. PubMed ID: 22280202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future.
    Godman B; Burkhardt T; Bucsics A; Wettermark B; Wieninger P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):475-84. PubMed ID: 19817531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient utilization patterns of the six main ATC drug groups in Republic of Croatia, city of Zagreb, and Croatia counties in 2004.
    Stimac D; Culig J; Vukusić I; Sostar Z; Tomić S; Bucalić M
    Coll Antropol; 2009 Dec; 33(4):1197-204. PubMed ID: 20102069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.
    Walley T; Folino-Gallo P; Stephens P; Van Ganse E
    Br J Clin Pharmacol; 2005 Nov; 60(5):543-51. PubMed ID: 16236045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular drugs consumption--comparison between two Croatian regions, City of Zagreb and Lika-Senj County.
    Jurković D; Stimac D; Bajramović D; Tiljak H; Stevanović R
    Coll Antropol; 2014 Jun; 38(2):645-52. PubMed ID: 25145001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.
    McGinn D; Godman B; Lonsdale J; Way R; Wettermark B; Haycox A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):73-85. PubMed ID: 20121565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy implications of rationalization of statin use in Lithuania.
    Kadusevicius E; Jankauskiene D; Paulauskaite I; Slapikas R
    Int J Technol Assess Health Care; 2009 Jul; 25(3):419-24. PubMed ID: 19619363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient utilization of psychopharmaceuticals: comparison between Croatia and Scandinavian countries (2001-2003).
    Stimac D; Vukusić I; Culig J; Sostar Z; Bucalić M
    Coll Antropol; 2009 Mar; 33(1):237-43. PubMed ID: 19408632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on the quality of outpatient prescription of psychopharmaceuticals in the City of Zagreb 2006-2009.
    Zivković K; Zelić-Kerep A; Stimac D; Ozić S; Zivković N
    Coll Antropol; 2014 Jun; 38(2):717-24. PubMed ID: 25145013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins reduce cardiovascular events in primary and secondary prevention trials without causing an increase in carcinoma.
    Aronow WS
    J Am Geriatr Soc; 2009 Oct; 57(10):1942-3; author reply 1943-4. PubMed ID: 19807799
    [No Abstract]   [Full Text] [Related]  

  • 16. Time trend analysis and variations in statins prescribing in the Czech Republic.
    Slanar O; Perlík F
    Prague Med Rep; 2006; 107(3):365-9. PubMed ID: 17385409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004.
    Divac N; Tosevski DL; Babić D; Djurić D; Prostran M; Samardzić R
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):835-8. PubMed ID: 16958148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of aspirin and statins for cardiovascular risk reduction in New Zealand: the residential care story.
    Hong JB; Kerse N; Scahill S; Moyes S; Chen C; Peri K; Hughes C
    J Prim Health Care; 2009 Sep; 1(3):184-9. PubMed ID: 20690381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
    Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based analysis of statin utilization in British Columbia.
    Raymond CB; Morgan SG; Katz A; Kozyrskyj AL
    Clin Ther; 2007 Sep; 29(9):2107-19. PubMed ID: 18035209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.